News & Events

In the news

Covid-19 information

Let us know if we can support you

Clean Cells, specialized in the detection of biological contaminant is always committed to contribute to the development of innovative drugs.

Covid-19 information

Clean Cells maintains its usual level of activity

In the context of the coronavirus (CoviD-19) epidemic, Clean Cells' teams are closely monitoring the evolution of the situation in order to guarantee business continuity but also to protect the safety and health of our employees.

BE Vaccines is now NAOBIOS

After joining Clean Cells on March 1st, 2019, BE Vaccines has been renamed NAOBIOS.

Created originally by the Valneva Group (ex-Vivalis) in 2005, then taken over by the Indian company Biological E in 2013 with the aim of stepping up the technical development of viral vaccines, BE VACCINES joined CLEAN CELLS on March 1st, 2019.

Press Release

CLEAN CELLS acquires BE VACCINES and demonstrates its development ambitions

On March 1st, 2019, Clean Cells acquired BE Vaccines, a French subsidiary of the Indian Pharmaceutical Company Biological E. Limited (BE).

Clean Cells’ Events

Meet with Clean Cells

In the first quarter, join the Clean Cells’ team at: PHAGE FUTURES CONGRESS, CarT CONGRESS EU, BACTERIOPHAGE THERAPY SUMMIT...

Clean Cells accelerates its developments

Clean Cells accelerates its developments with ArchiMed

Clean Cells opened its capital to ArchiMed to support its growth strategy in the biopharmaceutical sector.

Clean Cells’ Events

Meet with Clean Cells

In the fourth quarter, join the Clean Cells’ team at BioJapan, ESGCT, BioEurope...

Clean Cells’ Events

Meet with Clean Cells

Meet with Clean Cells. In the second quarter, join the Clean Cells’ team at: VIRAL SAFETY FOR BIOLOGICS, BIOMED...

ut sit vulputate, nunc ut at libero risus dapibus Lorem libero.